We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.89B
AUM Growth
+$1B
Cap. Flow
+$522M
Cap. Flow %
18.04%
Top 10 Hldgs %
47.96%
Holding
234
New
67
Increased
34
Reduced
17
Closed
35

Sector Composition

Rank Sector Weight
1 Financials 13.19%
2 Consumer Discretionary 12.8%
3 Healthcare 12.62%
4 Communication Services 6.86%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRSA
51
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$11.9M 0.41%
1,200,000
MAAC
52
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
$11.9M 0.41%
+1,200,000
New +$11.8M
DEO icon
53
Diageo
DEO
$49B
$11.8M 0.41%
61,800
-74,000
-54% -$13.8M
B
54
Barrick Mining
B
$61.5B
$11.4M 0.4%
553,477
-8,000
-1% -$180K
ZG icon
55
Zillow
ZG
$7.94B
$11M 0.38%
90,000
ATRA icon
56
Atara Biotherapeutics
ATRA
$75.5M
$10.5M 0.36%
27,107
+18,273
+207% +$6.52M
DHT icon
57
DHT Holdings
DHT
$2.99B
$10.5M 0.36%
1,616,100
PDYN icon
58
Palladyne AI
PDYN
$247M
$10M 0.35%
+167,247
New +$9.96M
UP icon
59
Wheels Up
UP
$208M
$9.98M 0.34%
+5,000
New +$10M
CRESY
60
Cresud
CRESY
$795M
$9.88M 0.34%
1,719,951
BSN
61
DELISTED
Broadstone Acquisition Corp.
BSN
$9.88M 0.34%
+1,000,000
New +$9.85M
CND
62
DELISTED
Concord Acquisition Corp.
CND
$9.85M 0.34%
1,000,000
RBOT
63
DELISTED
Vicarious Surgical
RBOT
$9.47M 0.33%
+31,667
New +$9.43M
TGTX icon
64
TG Therapeutics
TGTX
$7.96B
$9.44M 0.33%
243,271
MBTC
65
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
$9.37M 0.32%
+950,000
New +$9.35M
ALNY icon
66
Alnylam Pharmaceuticals
ALNY
$27.5B
$9.32M 0.32%
55,000
RSVR
67
DELISTED
Reservoir Media
RSVR
$9.3M 0.32%
936,624
+786,624
+524% +$7.88M
QURE icon
68
uniQure
QURE
$3.03B
$8.7M 0.3%
282,516
CUE icon
69
Cue Biopharma
CUE
$113M
$8.2M 0.28%
23,474
+12,226
+109% +$4.74M
BTWN
70
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$8.1M 0.28%
800,000
+195,943
+32% +$2.03M
FENC icon
71
Fennec Pharmaceuticals
FENC
$332M
$8.09M 0.28%
1,110,000
BTNB
72
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
$7.65M 0.26%
750,000
+242,651
+48% +$2.48M
CMPR icon
73
Cimpress
CMPR
$2.39B
$7.32M 0.25%
67,500
APTO
74
DELISTED
Aptose Biosciences, Inc.
APTO
$7.27M 0.25%
4,869
+3,534
+265% +$7.7M
TOI icon
75
The Oncology Institute
TOI
$486M
$7.12M 0.25%
+715,963
New +$7.21M

Similar funds

683 Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, 683 Capital Management held 234 positions worth $2.89B, up 53% from $1.89B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

683 Capital Management deployed $522M of net new capital in Q2 2021, opening 67 new positions and adding to 34 existing holdings. Its largest new stake was TWC Tech Holdings II Corp. Class A Common Stock: 3,756,134 shares worth $37.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was People Inc, an estimated $32.9M trimmed.

  • 683 Capital Management's largest Q2 2021 buy was TWC Tech Holdings II Corp. Class A Common Stock: 3,756,134 shares worth $37.3M.
  • 683 Capital Management added most to Cardlytics in Q2 2021, an estimated $59.9M increase.
  • 683 Capital Management's biggest Q2 2021 reduction was People Inc, cutting an estimated $32.9M.
  • 683 Capital Management fully exited Mudrick Capital Acquisition Corporation II Class A Common Stock in Q2 2021, selling an estimated $19.6M.
  • 683 Capital Management's ten largest holdings make up 48% of its $2.89B portfolio in Q2 2021.
  • 683 Capital Management opened 67 new positions and closed 35 in Q2 2021.
  • 683 Capital Management's portfolio value rose 53% quarter-over-quarter to $2.89B.

Based on 683 Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.